ZALAIN

This brand name is authorized in Ecuador, Germany, Hong Kong SAR China, Spain, Turkey.

Active ingredients

The drug ZALAIN contains one active pharmaceutical ingredient (API):

1	Sertaconazole UNII 1DV05410M5 - SERTACONAZOLE NITRATE
	Sertaconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. This enzyme functions to convert lanosterol to ergosterol. Ergosterol is a key component of fungal cell membranes and lack of this component leads to fungal cell injury by leakage of key constituents in the cytoplasm from the cell.
	Read more about Sertaconazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC14	Sertaconazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC14
G01AF19		G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06967387, 06967393
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	21.315-1-11-04, 21.316-1-10-04, 4739-MEE-0619
ES	Centro de información online de medicamentos de la AEMPS	59077
HK	Department of Health Drug Office	50619, 51145
SG	Health Sciences Authority	10933P, 11905P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699587102201, 8699587352187, 8699587653215, 8699587653222, 8699587654069, 8699587904058